{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:41:38Z","timestamp":1791333698778,"version":"4.3.1"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/version\/2\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084298"],"award-info":[{"award-number":["OPP1084298"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The MenAfriNet Consortium supports strategic implementation of case-based meningitis surveillance in key high-risk countries of the African meningitis belt: Burkina Faso, Chad, Mali, Niger, and Togo. We describe bacterial meningitis epidemiology in these 5 countries in 2015\u20132017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Case-based meningitis surveillance collects case-level demographic and clinical information and cerebrospinal fluid (CSF) laboratory results. Neisseria meningitidis, Streptococcus pneumoniae, or Haemophilus influenzae cases were confirmed and N. meningitidis\/H. influenzae were serogrouped\/serotyped by real-time polymerase chain reaction, culture, or latex agglutination. We calculated annual incidence in participating districts in each country in cases\/100 000 population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 2015\u20132017, 18 262 suspected meningitis cases were reported; 92% had a CSF specimen available, of which 26% were confirmed as N. meningitidis (n = 2433; 56%), S. pneumoniae (n = 1758; 40%), or H. influenzae (n = 180; 4%). Average annual incidences for N. meningitidis, S. pneumoniae, and H. influenzae, respectively, were 7.5, 2.5, and 0.3. N. meningitidis incidence was 1.5 in Burkina Faso, 2.7 in Chad, 0.4 in Mali, 14.7 in Niger, and 12.5 in Togo. Several outbreaks occurred: NmC in Niger in 2015\u20132017, NmC in Mali in 2016, and NmW in Togo in 2016\u20132017. Of N. meningitidis cases, 53% were NmC, 30% NmW, and 13% NmX. Five NmA cases were reported (Burkina Faso, 2015). NmX increased from 0.6% of N. meningitidis cases in 2015 to 27% in 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although bacterial meningitis epidemiology varied widely by country, NmC and NmW caused several outbreaks, NmX increased although was not associated with outbreaks, and overall NmA incidence remained low. An effective low-cost multivalent meningococcal conjugate vaccine could help further control meningococcal meningitis in the region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/infdis\/jiz358","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T15:08:49Z","timestamp":1562598529000},"page":"S165-S174","source":"Crossref","is-referenced-by-count":77,"title":["Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015\u20132017"],"prefix":"10.1093","volume":"220","author":[{"given":"Heidi M","family":"Soeters","sequence":"first","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpha Oumar","family":"Diallo","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice W","family":"Bicaba","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 du Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goumbi","family":"Kadad\u00e9","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 Publique du Niger, Niamey, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ass\u00e9tou Y","family":"Demb\u00e9l\u00e9","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 et de l\u2019Hygi\u00e8ne Publique, Bamako, Mali"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahamat A","family":"Acyl","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 Publique du Tchad, N\u2019Djamena, Tchad"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Nikiema","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 et de la Protection Sociale du Togo, Lom\u00e9, Togo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adodo Yao","family":"Sadji","sequence":"additional","affiliation":[{"name":"Minist\u00e8re de la Sant\u00e9 et de la Protection Sociale du Togo, Lom\u00e9, Togo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain N","family":"Poy","sequence":"additional","affiliation":[{"name":"World Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Lingani","sequence":"additional","affiliation":[{"name":"World Health Organization, AFRO Intercountry Support Team for West Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoua","family":"Tall","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9dicine Pr\u00e9ventive, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souleymane","family":"Sakand\u00e9","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9dicine Pr\u00e9ventive, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e9lix","family":"Tarbangdo","sequence":"additional","affiliation":[{"name":"Davycas International, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavien","family":"Ak\u00e9","sequence":"additional","affiliation":[{"name":"Davycas International, Ouagadougou, Burkina Faso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A","family":"Mbaeyi","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mo\u00efsi","sequence":"additional","affiliation":[{"name":"Agence de M\u00e9dicine Pr\u00e9ventive, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietou F","family":"Paye","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibayiri Osee","family":"Sanogo","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeni T","family":"Vuong","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Ronveaux","sequence":"additional","affiliation":[{"name":"World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T","family":"Novak;","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MenAfriNet Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"2019110101094049800_CIT0001","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson lecture. Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2019110101094049800_CIT0002","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"2019110101094049800_CIT0003","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1093\/infdis\/jiz336","article-title":"Status of the rollout of the meningococcal serogroup A conjugate vaccine in African meningitis belt countries in 2018","volume":"220","author":"Bwaka","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0004","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1473-3099(17)30301-8","article-title":"Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data","volume":"17","author":"Trotter","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2019110101094049800_CIT0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/cid\/cis892","article-title":"Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity","volume":"56","author":"Kristiansen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2019110101094049800_CIT0006","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz308","article-title":"MenAfriNet: a network supporting case-based meningitis surveillance and vaccine evaluation in the meningitis belt of Africa","author":"Patel","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0007","doi-asserted-by":"crossref","first-page":"e0166384","DOI":"10.1371\/journal.pone.0166384","article-title":"Nationwide trends in bacterial meningitis before the introduction of 13-valent pneumococcal conjugate vaccine-Burkina Faso, 2011\u20132013","volume":"11","author":"Kambire","year":"2016","journal-title":"PloS One"},{"key":"2019110101094049800_CIT0008","volume-title":"Technical guidelines for integrated disease surveillance and response in the African region","author":"World Health Organization","year":"2010","edition":"2nd ed."},{"key":"2019110101094049800_CIT0009","volume-title":"Standard operating procedures for case-based surveillance of meningitis, preparedness and response to meningitis epidemics","author":"World Health Organization-AFRO","year":"2017"},{"issue":"Suppl 4","key":"2019110101094049800_CIT0010","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1093\/infdis\/jiz303","article-title":"Improving case-based meningitis surveillance in 5 countries in the meningitis belt of sub-Saharan Africa, 2015\u20132017","volume":"220","author":"Mbaeyi","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0011","volume-title":"Standard operating procedures for enhanced meningitis surveillance in Africa","author":"World Health Organization-AFRO","year":"2009"},{"key":"2019110101094049800_CIT0012","volume-title":"Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae","author":"World Health Organization","year":"2011","edition":"2nd ed."},{"key":"2019110101094049800_CIT0013","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JCM.02498-06","article-title":"Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA","volume":"45","author":"Carvalho Mda","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2019110101094049800_CIT0014","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/JCM.06087-11","article-title":"Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens","volume":"50","author":"Wang","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2019110101094049800_CIT0015","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz337","article-title":"The strengthening of laboratory systems in the meningitis belt to improve meningitis surveillance, 2008\u20132018: a partners\u2019 perspective","author":"Feagins","year":"2019","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"2019110101094049800_CIT0016","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.1093\/infdis\/jiz301","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis\u2014Burkina Faso, 2016\u20132017","volume":"220","author":"Soeters","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0017","doi-asserted-by":"crossref","first-page":"e0187466","DOI":"10.1371\/journal.pone.0187466","article-title":"Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign","volume":"12","author":"Diallo","year":"2017","journal-title":"PLoS One"},{"key":"2019110101094049800_CIT0018","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz355","article-title":"Meningococcal meningitis outbreaks in the African meningitis belt after meningococcal serogroup A conjugate vaccine introduction, 2011\u20132017","author":"Fernandez","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0019","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S1473-3099(16)30253-5","article-title":"Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data","volume":"16","author":"Sidikou","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2019110101094049800_CIT0020","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz272","article-title":", Guindo I, Diarra S, et al. New sequence type of Neisseria meningitidis serogroup C associated with a 2016 meningitis outbreak in Mali","author":"Sanogo","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0021","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz330","article-title":"Neisseria meningitidis serogroup W meningitis epidemic in Togo, 2016","author":"Mounkoro","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0022","doi-asserted-by":"publisher","DOI":"10.1371\/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518","article-title":"Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013\u201314","volume":"6","author":"Funk","year":"2014","journal-title":"PLoS Curr"},{"issue":"Suppl 4","key":"2019110101094049800_CIT0023","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1093\/infdis\/jiz343","article-title":"Spatio-temporal analysis of serogroup C meningococcal meningitis spread in Niger and Nigeria and implications for epidemic response","volume":"220","author":"Cooper","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0024","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3201\/eid2210.160468","article-title":"Whole-genome characterization of epidemic Neisseria meningitidis serogroup C and resurgence of serogroup W, Niger, 2015","volume":"22","author":"Kretz","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"2019110101094049800_CIT0025","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz297","article-title":"Eliminating meningococcal epidemics from the African meningitis belt: the case for advanced prevention and control using next generation meningococcal conjugate vaccines","author":"Alderson","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0026","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/511646","article-title":"Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger","volume":"44","author":"Boisier","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019110101094049800_CIT0027","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1046\/j.1360-2276.2003.01126.x","article-title":"Outbreaks of serogroup X meningococcal meningitis in Niger 1995\u20132000","volume":"8","author":"Djibo","year":"2003","journal-title":"Trop Med Int Health"},{"key":"2019110101094049800_CIT0028","doi-asserted-by":"crossref","first-page":"e19513","DOI":"10.1371\/journal.pone.0019513","article-title":"Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso","volume":"6","author":"Delrieu","year":"2011","journal-title":"PLoS One"},{"key":"2019110101094049800_CIT0029","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/506940","article-title":"Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso","volume":"43","author":"Yaro","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2019110101094049800_CIT0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(13)61612-8","article-title":"Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]","volume":"383","author":"Daugla","year":"2014","journal-title":"Lancet"},{"key":"2019110101094049800_CIT0031","volume-title":"Standard operating procedures for surveillance of meningitis, preparedness and response to epidemics in Africa","author":"World Health Organization","year":"2018"},{"issue":"Suppl 4","key":"2019110101094049800_CIT0032","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1093\/infdis\/jiz421","article-title":"Future directions for meningitis surveillance and vaccine evaluation in the meningitis belt of sub-Saharan Africa","volume":"220","author":"Novak","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0033","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/cid\/civ596","article-title":"Community perspectives associated with the African PsA-TT (MenAfriVac) vaccine trials","volume":"61","author":"Idoko","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019110101094049800_CIT0034","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(18)30674-1","article-title":"Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials","volume":"19","author":"White","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2019110101094049800_CIT0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/cid\/ciy488","article-title":"Antibody persistence at the population level 5 years after mass vaccination with meningococcal serogroup a conjugate vaccine (PsA-TT) in Burkina Faso: need for a booster campaign?","volume":"68","author":"Yaro","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019110101094049800_CIT0036","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1093\/cid\/civ490","article-title":"A vaccine meets its promise: success in controlling epidemic meningitis in sub-Saharan Africa","volume":"61","author":"Sambo","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019110101094049800_CIT0037","doi-asserted-by":"crossref","first-page":"G41","DOI":"10.1016\/j.vaccine.2012.10.052","article-title":"Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007\u20132009","volume":"30","author":"Gessner","year":"2012","journal-title":"Vaccine"},{"key":"2019110101094049800_CIT0038","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1086\/596498","article-title":"Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo","volume":"48","author":"Traore","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2019110101094049800_CIT0039","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jinf.2017.12.002","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis\u2014Burkina Faso, 2014\u20132015","volume":"76","author":"Kambire","year":"2018","journal-title":"J Infect"},{"key":"2019110101094049800_CIT0040","doi-asserted-by":"crossref","first-page":"e0203205","DOI":"10.1371\/journal.pone.0203205","article-title":"Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine","volume":"13","author":"Bozio","year":"2018","journal-title":"PLoS One"},{"key":"2019110101094049800_CIT0041","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz376","article-title":"Development and implementation of a cloud-based meningitis surveillance and specimen tracking system in Burkina Faso, 2018","author":"Diallo","year":"2019","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"2019110101094049800_CIT0042","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1093\/infdis\/jiz251","article-title":"Invasive meningococcal disease in Africa\u2019s meningitis belt: more than just meningitis?","volume":"220","author":"Reese","year":"2019","journal-title":"J Infect Dis"},{"key":"2019110101094049800_CIT0043","first-page":"179","article-title":"Epidemic meningitis control in countries in the African meningitis belt, 2018","volume":"94","author":"World Health Organization","year":"2019","journal-title":"Wkly Epidemiol Rec"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/Supplement_4\/S165\/30339628\/jiz358.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/Supplement_4\/S165\/30339628\/jiz358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T01:10:13Z","timestamp":1572570613000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/Supplement_4\/S165\/5610772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":43,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2019,10,31]]},"published-print":{"date-parts":[[2019,10,31]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz358","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12,1]]},"published":{"date-parts":[[2019,10,31]]}}}